MFDS — authorised 12 January 1972
- Marketing authorisation holder: ALLERGAN
- Status: likely_approved
MFDS authorised Fml on 12 January 1972
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 12 January 1972.
ALLERGAN holds the South Korean marketing authorisation.